A recent report from the Institute of Medicine (IOM) recommends that Congress require the Centers for Medicare & Medicaid Services to cut its physician payments and pool the money to award those who demonstrate "high-quality, patient-centered and efficient care," reported Modern Healthcare (9/25/2006).
A recent report from the Institute of Medicine (IOM) recommends that Congress require the Centers for Medicare & Medicaid Services to cut its physician payments and pool the money to award those who demonstrate "high-quality, patient-centered and efficient care," reported Modern Healthcare (9/25/2006). The IOM left the decision of how much to reduce payments to Congress and also noted that the amount would have to be large enough to prompt physicians into action.
The recommendation is likely to be a hard sell for physician groups who have been working hard to fight a 5.1% cut in Medicare reimbursements scheduled to take effect next year. Despite the flak from medical groups, Robert Reischauser, president of the Urban Institute and a co-chairman on the IOM panel that made the pay-for-performance recommendation, believes that this model could be accepted by physicians "as long as it's done right."
Variations found in testosterone therapy for women with HSDD
May 7th 2024Dive into the intricate landscape of testosterone therapy prescriptions among women with hypoactive sexual desire disorder, revealing diverse patterns in duration, administration routes, and estrogen co-administration.
Read More
Impact of weight, ferritin, and nutrition education on postpartum depression risk
May 7th 2024A recent study highlights the role of weight gain, ferritin levels, and nutritional education in influencing the risk of postpartum depression among pregnant women, urging for proactive measures during routine prenatal care.
Read More
Pioglitazone outperforms metformin in IVF for PCOS-related infertility
May 6th 2024A recent double-blind, randomized clinical trial revealed a higher clinical pregnancy rate with pioglitazone compared to metformin in polycystic ovarian syndrome patients undergoing in vitro fertilization, suggesting potential for improved outcomes.
Read More